Sam from Pakistan is an overseas student of China University of Science and Technology. On the eve of graduation , he successfully received an operation in Anhui Province to cure his heart disease.
It is reported that Sam, with outstanding achievements, received a full scholarship from the University of Science and Technology of China three years ago to study for a doctorate in chemistry. This year is his last year of studying in China. At the end of 2017, Sam suffered from chest pain and discomfort, with intermittent pain, which radiated to his neck and left arm. In February 2019, Sam’s chest pain and tightness symptoms continued to worsen with palpitation and shortness of breath.When Sam returned home to visit relatives, he was diagnosed to have hypertrophic obstructive cardiomyopathy in Peshawar Hospital, Pakistan. Local doctors recommended Sam to go to China or the United States for surgery.
Accompanied by his wife, Sam decided to come to China for surgery. After considering the medical level, service ability and convenience of Beijing, Shanghai and Anhui, Sam came to the Department of Cardiovascular Surgery in the South of the First Affiliated Hospital of China University of Science and Technology. After examination, it was diagnosed that he had asymmetric left ventricular wall thickening, mitral and aortic regurgitation, and the thickness of interventricular septum was 31 mm, which was far beyond the normal range.
Sam is a rare Rh-negative blood group in China, called “panda blood”. In order to carry out the operation in time ,the hospital contacted the central blood station in Hefei. At the same time, it launched a panda blood search campaign on the campus of the University of Science and Technology, which solved the problem of blood donation during the operation in a short time. On March 12, after careful preoperative preparation, the Morrow operation was successfully completed . Thickened septal muscle bundles were successfully resected and the left and right ventricular outflow tract stenosis were dredged.
Doctors explained that hypertrophic obstructive cardiomyopathy is a cardiac disease characterized by ventricular hypertrophy. Its etiology is not yet clear. It may be related to heredity and endocrine disorders. It is usually chromosome dominant inheritance, and about 1/3 has family history. Most of the symptoms begin before the age of 30, usually manifested as fatigue dyspnea, pre-cardiac pain and palpitation, fatigue, syncope and other clinical manifestations. If there are similar symptoms, it is recommended to go to the hospital in time for medical treatment, and carry out relevant examinations and symptomatic treatment.